Evidence map›Paper›PMID 40123200›Full record

ArticleThe FEBS journal2025

Mammalian TatD DNase domain containing 1 (TATDN1) is a proteostasis-responsive gene with roles in ventricular structure and neuromuscular function.

Gisel Barés, Aida Beà, Anna Sancho-Balsells, Juan G Valero, David Aluja, Javier Inserte, Sandra García-Carpi, Elisabet Miró-Casas, Sara Borràs-Pernas, Sara Hernández and 10 more

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Gisel BarésCell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.
Aida BeàCell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.ORCID https://orcid.org/0000-0002-9733-4618
Anna Sancho-BalsellsDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.
Juan G ValeroDepartment of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.ORCID https://orcid.org/0000-0003-3193-9099
David AlujaCardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.ORCID https://orcid.org/0000-0002-0448-9419
Javier InserteCardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.ORCID https://orcid.org/0000-0002-4736-5010
Sandra García-CarpiCell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.
Elisabet Miró-CasasCardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.
Sara Borràs-PernasDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.
Sara HernándezIRBLleida, Lleida, Spain.ORCID https://orcid.org/0000-0002-6451-724X
Ana Martínez-ValNovo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-8784-3822
Jesper V OlsenNovo Nordisk Foundation Center for Protein Research, Proteomics Program, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark.ORCID https://orcid.org/0000-0002-4747-4938
Francesc TebarDepartament de Biomedicina, Unitat de Biologia Cellular, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Spain.ORCID https://orcid.org/0000-0002-9522-9726
Xavier CañasInstitut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.
Joan X ComellaInstitut de Recerca Sant Joan de Deu Barcelona, Madrid, Spain.
Patricia Pérez-GalánDepartment of Hematology-Oncology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain.ORCID https://orcid.org/0000-0003-3895-5024
Marisol Ruiz-MeanaCardiovascular Diseases Group, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Hospital Universitari and Universitat Autònoma de Barcelona, Spain.ORCID https://orcid.org/0000-0002-4067-4638
Albert GiraltDepartament de Biomedicina, Facultat de Medicina, Institut de Neurociències, Universitat de Barcelona, Spain.ORCID https://orcid.org/0000-0001-5334-0963
Marta LloveraCell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.ORCID https://orcid.org/0000-0001-8399-6867
Daniel SanchisCell Signaling and Apoptosis Group, Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Spain.ORCID https://orcid.org/0000-0003-0047-8533

Funding

Agència de Gestió d'Ajuts Universitaris i de Recerca 2014-SGR-1609Agència de Gestió d'Ajuts Universitaris i de Recerca AGAUR_2024_FI-1_00908Fundació la Marató de TV3 20153810H2020 European Research Council EPIC-XS-823839Instituto de Salud Carlos III PI19-01196Instituto de Salud Carlos III PI20-01681Ministerio de Ciencia, Innovación y Universidades MDM-2017-0729Ministerio de Ciencia, Innovación y Universidades PID2019-104509RB-I00Ministerio de Ciencia, Innovación y Universidades PID2021-122258OB-I00Ministerio de Ciencia, Innovación y Universidades PID2022-139965OB-100Ministerio de Ciencia, Innovación y Universidades RYC-2016-19466Novo Nordisk Foundation Center for Protein Research, University of Copenhagen NNF14CC0001
6 · The paper itself

Abstract

The characterization of highly conserved but poorly understood genes often reveals unexpected biological roles, advancing our understanding of disease mechanisms. One such gene is Mammalian TatD DNase domain containing 1 (Tatdn1), the mammalian homolog of bacterial Twin-arginine translocation D (TatD), a protein proposed to have roles either in DNA degradation or protein quality control in unicellular organisms. Despite its association with different pathologies, including several cancer types and cardiovascular diseases, the role of TATDN1 in mammals remains unexplored. Here, we demonstrate that Tatdn1 encodes a cytoplasmic protein that does not participate in DNA degradation but is upregulated in cells under proteostasis stress. Tatdn1-deficient mice exhibit dysregulated expression of genes involved in membrane and extracellular protein biology, along with mild dilated cardiomyopathy and impaired motor coordination. These findings identify TATDN1 as a key player in cytosolic processes linked to protein homeostasis, with significant physiological implications for cardiac and neurological function.

Indexed as

Cardiomyopathy, DilatedDNA-Binding ProteinsHeart VentriclesProteostasisAnimalsHumansMiceMice, KnockoutDNA-Binding Proteinscardiomyopathymotor controlneurobehaviorTatDTatdn1ventricle dilation

Identifiers

PMID40123200
PMCPMC12505432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.